Search
for
Sort by
Research 571–600 of 1000+
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Title Choice of treatment for severe forms of alopecia areata (case reports)
- Alopecia areata: Time for position statement to include new systemic therapeutic advances
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Dermatological diseases from a genetic perspective
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- New Modalities in the Treatment of Refractory Alopecia Areata
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Exploring novel management options for alopecia areata
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Review of efficacy of baricitinib in the treatment of alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Pathomechanisms of immune-mediated alopecia
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement